Literature DB >> 3027154

Imipramine prevention of carbon tetrachloride-induced liver necrosis at late states of the intoxication process.

G Fernández, M C Villarruel, E C de Ferreyra, O M de Fenos, J A Castro.   

Abstract

Imipramine administration (50 mg kg-1, i.p.) to Sprague-Dawley male rats (240-290 g) 6 or 10 h after CCl4 (1 ml kg-1, i.p.) partially prevents liver necrosis induced by the hepatotoxin. When imipramine is given 30 min before CCl4, it inhibits in part the CCl4-induced lipid peroxidation and the covalent interactions of reactive metabolites with microsomal lipids or proteins and partially prevents CCl4-induced cytochrome P-450 destruction, but not glucose 6 phosphatase activity depression. Imipramine administration prior to CCl4 does not modify levels of the hepatotoxin reaching the liver or the body temperature of CCl4 treated animals. Early preventive effects of imipramine on cytochrome P-450, might be attributed to inhibition of covalent interactions of reactive metabolites. The hypothesis that imipramine exerted late preventive effects by interfering with calcium deleterious effects or by modulation of protein and phospholipid synthesis or degradation is analyzed.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3027154     DOI: 10.1002/jat.2550060606

Source DB:  PubMed          Journal:  J Appl Toxicol        ISSN: 0260-437X            Impact factor:   3.446


  2 in total

1.  Late preventive effects against carbon tetrachloride-induced liver necrosis of the calcium chelating agent Calcion.

Authors:  E C de Ferreyra; M C Villarruel; A S Bernacchi; G Fernández; O M de Fenos; J A Castro
Journal:  Arch Toxicol       Date:  1989       Impact factor: 5.153

2.  Octacosanol attenuates disrupted hepatic reactive oxygen species metabolism associated with acute liver injury progression in rats intoxicated with carbon tetrachloride.

Authors:  Yoshiji Ohta; Koji Ohashi; Tatsuya Matsura; Kenji Tokunaga; Akira Kitagawa; Kazuo Yamada
Journal:  J Clin Biochem Nutr       Date:  2008-03       Impact factor: 3.114

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.